ライフサイエンスコーパス: decaffeinated

1 criminant Analysis) to differentiate between decaffeinated and highly caffeinated yerba mate.

2 nce = 29.6 ml) of coffee per week (including decaffeinated) at the last menstrual period; and were en

3 demiologic studies link caffeinated (but not decaffeinated) beverage intake with significant decrease

4 tea, decaffeinated green tea plus caffeine, decaffeinated black tea plus caffeine, or caffeine alone

5 and controls from the SCCS drank regular or decaffeinated coffee >= 2 times/day.

6 High intake of caffeinated and decaffeinated coffee (2 or more cups/day) was associated

7 oup), while 17 matched participants received decaffeinated coffee (DECAF group).

8 caffeinated (P value for trend < 0.001) and decaffeinated coffee (P value for trend = 0.022).

9 udy, we associated intake of caffeinated and decaffeinated coffee after diagnosis of CRC with lower r

10 No association between decaffeinated coffee and bladder cancer was observed amo

11 Similar findings were observed for decaffeinated coffee and coffee additives.

12 Similar associations were found for decaffeinated coffee and for coffee with additives.Drink

13 arts and that the neuroprotective effects of decaffeinated coffee and nicotine-free tobacco are also

14 We further report that decaffeinated coffee and nicotine-free tobacco are as ne

15 e report that the neuroprotective effects of decaffeinated coffee and nicotine-free tobacco require t

16 completely abstain from both caffeinated and decaffeinated coffee and other caffeine-containing produ

17 ation between consumption of caffeinated and decaffeinated coffee and risk of mortality remains incon

18 Further investigations of decaffeinated coffee and tea intake as arthritis risk fa

19 Intakes of decaffeinated coffee and tea were not associated with ri

20 association between consumption of coffee or decaffeinated coffee and the risk of rheumatoid arthriti

21 An observed higher lung cancer risk for decaffeinated coffee attenuated to null when restricted

22 concluded that ingestion of caffeinated and decaffeinated coffee can reduce the risk of diabetes.

23 variate model using only baseline reports of decaffeinated coffee consumption (RR 1.0, 95% CI 0.6-1.7

24 s of RA onset with the highest categories of decaffeinated coffee consumption (RR 3.10, 95% CI 1.75-5

25 ociation was observed between caffeinated or decaffeinated coffee consumption and risk of falls with

26 d not find a significant association between decaffeinated coffee consumption of >/=4 cups/day (compa

27 Decaffeinated coffee consumption was assessed at baselin

28 Decaffeinated coffee consumption was associated with a s

29 Higher decaffeinated coffee consumption was associated with low

30 Decaffeinated coffee consumption was not associated with

31 nsumption of >/=4 cups/day (compared with no decaffeinated coffee consumption) and subsequent risk of

32 and 14 site-specific cancers associated with decaffeinated coffee consumption, adjusted for regular c

33 ine intake from all sources combined or with decaffeinated coffee consumption.

34 One short-term study found that ground decaffeinated coffee did not increase blood pressure.

35 Decaffeinated coffee did not increase risk for any perin

36 as associated with a greater odds of being a decaffeinated coffee drinker (MREggr OR: 1.71; 95% CI: 1

37 caffeinated coffee and to be non-habitual or decaffeinated coffee drinkers compared with those who di

38 t from comparisons with coffee abstainers or decaffeinated coffee drinkers.

39 us and will guide research towards naturally-decaffeinated coffee drinks for consumers.

40 were seen for substitution of caffeinated or decaffeinated coffee for low-calorie soda.

41 ted coffee high in chlorogenic acid (C-HCA), decaffeinated coffee high in chlorogenic acid, or decaff

42 o examine the consumption of caffeinated and decaffeinated coffee in relation to cardiovascular disea

43 < 0.0001) and 4% for caffeinated and 7% for decaffeinated coffee in the HPFS (P < 0.01)].

44 [RR per serving: 8% for both caffeinated and decaffeinated coffee in the NHS (P < 0.0001) and 4% for

45 After adjustment for caffeinated and decaffeinated coffee intake amounts, sleep hours, and ot

46 Similar inverse associations were found with decaffeinated coffee intake and abnormal levels of ALT (

47 and cognitive function among men or between decaffeinated coffee intake and cognitive function in ei

48 Decaffeinated coffee intake is independently and positiv

49 lly, few studies have considered exclusively decaffeinated coffee intake or use of coffee additives.

50 an systolic or diastolic blood pressure, but decaffeinated coffee intake was associated with a small

51 Overall, decaffeinated coffee intake was not associated with high

52 Decaffeinated coffee intake was not associated with mean

53 Higher decaffeinated coffee intake was not associated with tota

54 An inverse association for >2 cups/day of decaffeinated coffee intake was suggested (relative risk

55 s, 0.1-0.9, 1-1.9, 2-2.9 and >=3 cups/day of decaffeinated coffee intake were associated with HRs of

56 examined the association of caffeinated and decaffeinated coffee intake with cognitive function in a

57 However, it is unclear whether decaffeinated coffee is also associated with liver enzym

58 In contrast, neither decaffeinated coffee nor tea was associated with SHBG or

59 products (caffeinated soda, caffeinated tea, decaffeinated coffee or chocolate) and risk of EG/EGS (P

60 in a double-blind design, 40 mL of either a decaffeinated coffee preparation plus 3 mg caffeine/kg (

61 ncer risk from methylene chloride residue in decaffeinated coffee remains unclear.

62 However, the ability of decaffeinated coffee to achieve these effects is based o

63 The odds ratio for drinking > 1 cup/day of decaffeinated coffee versus nondrinkers was 1.25 (95% CI

64 nversely, the consumption of caffeinated and decaffeinated coffee was associated with a lower risk of

65 Decaffeinated coffee was associated with a trend toward

66 ion of total coffee, caffeinated coffee, and decaffeinated coffee was associated with lower risk of t

67 In contrast, decaffeinated coffee was not associated with a decreased

68 affeine from sources other than coffee or of decaffeinated coffee was not associated with reduced liv

69 Decaffeinated coffee was not associated with risk of fal

70 In contrast, decaffeinated coffee was not associated with risk.

71 o use, subjects drinking > or =4 cups/day of decaffeinated coffee were at increased risk of RA (RR 2.

72 Consumption of total, caffeinated, and decaffeinated coffee were nonlinearly associated with mo

73 Nonherbal tea and decaffeinated coffee were not associated with patient ou

74 There were no significant associations of decaffeinated coffee with liver markers.

75 feinated coffee high in chlorogenic acid, or decaffeinated coffee with regular amounts of chlorogenic

76 ns of consumption of total, caffeinated, and decaffeinated coffee with risk of subsequent total and c

77 coffee, 10% (95% confidence interval 4-15%); decaffeinated coffee, 10% (3-16%); tea, 14% (5-22%); bee

78 r caffeinated coffee, 9% (CI, 2% to 15%) for decaffeinated coffee, 8% (CI, 1% to 15%) for tea, and 59

79 intake (mg/d) or cups of caffeinated coffee, decaffeinated coffee, and caffeinated tea.

80 se findings suggest that caffeinated coffee, decaffeinated coffee, and caffeine are not risk factors

81 The mean intakes of caffeinated coffee, decaffeinated coffee, and caffeine were 2-3 cups/d, 1 cu

82 Intakes of caffeinated coffee, decaffeinated coffee, and caffeine were not associated w

83 s of baseline intakes of caffeinated coffee, decaffeinated coffee, and caffeine with measured systoli

84 Total caffeine, regular coffee, decaffeinated coffee, and regular tea intake were not as

85 examined associations of caffeinated coffee, decaffeinated coffee, and tea intake with fatal oral/pha

86 gated the association of caffeinated coffee, decaffeinated coffee, and tea with myocardial infarction

87 VD was elevated for nondrinkers, drinkers of decaffeinated coffee, and those who reported drinking >6

88 ongitudinal relations of caffeinated coffee, decaffeinated coffee, and total caffeine intakes with me

89 e evidence of an association between coffee, decaffeinated coffee, or tea consumption and the risk of

90 We assessed the consumption of coffee, decaffeinated coffee, tea, and total caffeine in partici

91 For decaffeinated coffee, the multivariate relative risks co

92 For decaffeinated coffee, the multivariate RRs according to

93 Decaffeinated coffee, therefore, may be the type of coff

94 We studied whether coffee, decaffeinated coffee, total coffee, tea, or overall caff

95 l cancers for people who drank predominantly decaffeinated coffee.

96 0.001), and tea (p for trend = 0.02) but not decaffeinated coffee.

97 Trends were similar between caffeinated and decaffeinated coffee.

98 ving of sugar-sweetened soda/d, 1 serving of decaffeinated coffee/d was associated with a 10% (95% CI

99 sumption categories (0, 1-237, and >/=237 mL decaffeinated coffee/d) were 1.00, 1.02, and 0.77 (95% C

100 nated coffee/mo and 75% consumed > or =1 cup decaffeinated coffee/mo; the corresponding intakes for w

101 seen for diet cola and, although weaker, for decaffeinated cola.

102 ndomly assigned to consumption of either the decaffeinated energy drink or a placebo drink on testing

103 The efficacy of decaffeinated energy drinks in enhancing subjective feel

104 different characteristics (soluble, ground, decaffeinated, etc) were evaluated for antioxidant capac

105 e relation between long-term caffeinated and decaffeinated filtered coffee consumption and markers of

106 esults indicate that neither caffeinated nor decaffeinated filtered coffee has a detrimental effect o

107 to test the effect of acute consumption of a decaffeinated green coffee extract (DGCE), rich in CGAs,

108 Oral administration of decaffeinated green or black tea resulted in substantial

109 caffeinated beverages (green tea, black tea, decaffeinated green tea plus caffeine, decaffeinated bla

110 0.77; 95% CI: 0.63, 0.94; P-trend 0.009) and decaffeinated (HR: 0.70; 95% CI: 0.46, 1.06; P-trend: 0.

111 affeinated (HR: 0.94; 95% CI: 0.84, 1.05) or decaffeinated (HR: 1.05; 95% CI: 0.84, 1.31) coffee cons

112 ated coffee and tea intakes (caffeinated and decaffeinated) in relation to colon (proximal and distal

113 (FDIT), spray-dried instant tea (SDIT), and decaffeinated instant tea (DCIT)], were compared for the

114 tives.Drinking coffee, either caffeinated or decaffeinated, may lower the risk of CVD and IHD mortali

115 aximum intensity, intermediate intensity and decaffeinated) prepared from coffee capsules, using gas

116 , administration of a high-dose level of the decaffeinated teas enhanced the tumorigenic effect of UV

117 Administration of the decaffeinated teas had little or no effect on these para

118 d carcinogenesis, and adding caffeine to the decaffeinated teas restored the inhibitory effects of th

119 nt to the amount in the regular teas) to the decaffeinated teas restored their inhibitory effects.